SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974158-23-000010
Filing Date
2023-06-02
Accepted
2023-06-02 16:26:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4586
  Complete submission text file 0001974158-23-000010.txt   6317
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36483 | Film No.: 23989211
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O VIRIDIAN THERAPEUTICS, INC. 203 CRESCENT STREET, BLDG. 17, SUITE 102 WALTHAM MA 02453
Business Address
Meisner Lara (Reporting) CIK: 0001883986 (see all company filings)

Type: 144